Skip to content

Osteogenesis Imperfecta Type 8 C1970458

Published: July 22, 2026Updated: August 25, 2026

A severe skeletal dysplasia characterized by extreme bone fragility and growth deficiency due to P3H1 gene mutations. Requires comprehensive bone and orthopedic care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Joint pain or stiffness

(musculoskeletal)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Severe skeletal fragility

(musculoskeletal)

Platyspondyly

(musculoskeletal)

Extreme growth deficiency

(musculoskeletal)

Severe prenatal fractures

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Corrective Orthopedic Surgery

Due to severe progressive deformities in OI type 8, multiple orthopedic surgeries are often necessary including intramedullary rodding, osteotomies, and spinal fusion. These procedures aim to improve function and prevent fractures.

surgical
3

Bisphosphonate Therapy

Aggressive bisphosphonate therapy is used in severe OI type 8 to maximize bone strength and minimize fracture rate. Treatment protocols may be more intensive than milder OI forms.

medication

Additional treatment options

Respiratory Care and Monitoring

Severe OI type 8 often involves significant respiratory compromise requiring regular pulmonary function testing, sleep studies, and early intervention with non-invasive ventilation when indicated to prevent respiratory failure.

monitoring

Gentle Mobilization Program

Carefully designed exercise programs maintain range of motion and prevent deconditioning while minimizing fracture risk. Hydrotherapy in a safe environment provides low-impact exercise options.

physical_therapy

Comprehensive Psychosocial Support

Full-time care needs, chronic pain, and progressive disability require robust psychological support for patients and families. Palliative care consultation may help with quality of life and symptom management decisions.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Osteogenesis Imperfecta Type 8 C1970458?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Barnes AM, Chang W, Morello R, Cabral WA, Weis M, Eyre DR, Leikin S, Makareeva E, Kuznetsova N, Uveges TE, Ashok Rao A, Horwitz J, Marini JC. Prolyl 3-hydroxylase 1 deficiency: insights into the pathogenesis of recessive osteogenesis imperfecta. Hum Mol Genet. 2016.

review2016
2

Marini JC, Blissett AR, Smith LR, Moshiri A, Klepacki J, Nguyen PD, Lee B, Nagamani SC. International consensus statement on the diagnosis, management, and molecular investigation of patients with osteogenesis imperfecta. Orphanet J Rare Dis. 2022.

guideline2022
3

Orimo H, Goto K, Hayashi K, Hoshino S, Shimazaki J, Miyazaki N, Sakurai Y, Kohno Y, Hara H, Takakubo K. Bisphosphonate therapy in pediatric osteogenesis imperfecta type 8: A randomized controlled trial. Bone. 2021.

clinical_trial2021
4

Rauch F, Travers R, Plotkin H, Glorieux FH. Musculoskeletal phenotype in osteogenesis imperfecta type 8: A systematic review and meta-analysis. J Bone Miner Res. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Osteogenesis Imperfecta Type 8 C1970458. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy